FDA inspection
Genzyme Flanders BVBA (dba Sanofi Genzyme Geel): FDA inspection ending Sep 28, 2018
FDA inspection 1077100 · Voluntary Action Indicated (VAI) · Geel
Key facts
| Inspection ID | 1077100 |
|---|---|
| Firm | Genzyme Flanders BVBA (dba Sanofi Genzyme Geel) |
| FEI number | 3003623839 |
| Address | Cipalstraat 8 |
| City | Geel |
| Fiscal year | 2018 |
| Inspection end date | Sep 28, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data